Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages.
Antimicrobial agents and chemotherapy, 2026
doi:10.1128/aac.01319-25.
A facility for large-scale microbial cultivation, genetics and phenotyping.
Showing results out of
Antimicrobial agents and chemotherapy, 2026
doi:10.1128/aac.01319-25.
Nature communications, 2025
doi:10.1038/s41467-025-58730-5.
Cell reports, 2024
doi:10.1016/j.celrep.2023.113517.
Cell reports, 2024
doi:10.1016/j.celrep.2023.113519.
eLife, 2017
doi:10.7554/eLife.31035.
Nature Microbiology, 2017
doi:10.1038/nmicrobiol.2017.14.
eLife, 2015
doi:10.7554/elife.07118.
Proceedings of the National Academy of Sciences of the United States of America, 2014
doi:10.1073/pnas.1400376111.
No matching publications found